If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
687.00    0.00 (0.00%)
Bid:
680.00
Ask:
694.00
Spread: 14.00 (2.059%)
Market Cap: £242.09m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

27 Mar 2025 07:00

RNS Number : 3918C
B.P. Marsh & Partners PLC
27 March 2025
 

27 March 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

Issue of Share Options & Director/PDMR Dealings

 

B.P. Marsh, the specialist investor in early-stage financial services businesses, announces the granting of an aggregate of 490,000 Options over ordinary shares of 10p each in the Company to certain Directors and other employees of the Company.

 

The 490,000 Options were granted following the lapse of 490,000 Options, 400,000 of which had previously been granted to former Persons Discharging Managerial Responsibilities ("PDMR") as announced on 15 November 2023. The total number of Options that have been granted (being 1,685,000) remains unchanged.

 

Certain Directors who are PDMRs have been awarded Options with details of those awards in the disclosure notices below. The remaining Options have been granted to other employees of B.P. Marsh.

 

The Options have been granted under, and will vest in accordance with, the Company's existing Share Option Plan (the "Plan"), as announced on 15 November 2023 and 20 November 2023.

 

The total number of Options granted under the Plan represents approximately 4.35% of the fully diluted shares outstanding.

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

    

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alice Foulk

2

Reason for notification

a)

Position / status

Managing Director (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

90,000

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Chief Investment Officer (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

90,000

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Francesca Chappell

2

Reason for notification

a)

Position / status

Group Finance Director (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

62,500

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for over ten years. 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBCGDXRDDDGUL
Date   Source Headline
18th Jul 202411:19 amRNSTransaction in Own Shares
16th Jul 20243:20 pmRNSTransaction in Own Shares
12th Jul 20248:35 amRNSTransaction in Own Shares
10th Jul 20242:48 pmRNSTransaction in Own Shares
8th Jul 202411:05 amRNSTransaction in Own Shares
4th Jul 20242:20 pmRNSTransaction in Own Shares
3rd Jul 20241:19 pmRNSTransaction in Own Shares
2nd Jul 20241:07 pmRNSTransaction in Own Shares
28th Jun 20249:20 amRNSTransaction in Own Shares
27th Jun 20244:58 pmRNSNotice of AGM & Change of Name of NOMAD and Broker
20th Jun 202410:47 amRNSTransaction in Own Shares
19th Jun 20249:17 amRNSTransaction in Own Shares
13th Jun 20242:28 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:01 amRNSShare Buy-Back Programme
11th Jun 20247:00 amRNSFinal Results for the Year to 31 January 2024
29th May 20247:00 amRNSNotice of Results
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.